TMEM11
gene geneOn this page
Also known as PMIPM1
Summary
TMEM11 (transmembrane protein 11, HGNC:16823) is a protein-coding gene on chromosome 17p11.2, encoding Transmembrane protein 11, mitochondrial (P17152). Plays a role in mitochondrial morphogenesis.
Involved in mitochondrion organization. Located in mitochondrial inner membrane.
Source: NCBI Gene 8834 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 20 total
- MANE Select transcript:
NM_003876
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16823 |
| Approved symbol | TMEM11 |
| Name | transmembrane protein 11 |
| Location | 17p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PMI, PM1 |
| Ensembl gene | ENSG00000178307 |
| Ensembl biotype | protein_coding |
| OMIM | 618817 |
| Entrez | 8834 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding_CDS_not_defined, 3 protein_coding
ENST00000317635, ENST00000577419, ENST00000583264, ENST00000583929, ENST00000584432, ENST00000584732, ENST00000873639, ENST00000918692
RefSeq mRNA: 1 — MANE Select: NM_003876
NM_003876
CCDS: CCDS11216
Canonical transcript exons
ENST00000317635 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001346524 | 21214091 | 21214161 |
| ENSE00002712220 | 21197954 | 21198840 |
Expression profiles
Bgee: expression breadth ubiquitous, 278 present calls, max score 96.95.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 35.4389 / max 143.4590, expressed in 1820 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164923 | 33.9254 | 1820 |
| 164924 | 0.7590 | 517 |
| 164926 | 0.6776 | 382 |
| 164925 | 0.0770 | 27 |
Top tissues by expression
287 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 96.95 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.84 | gold quality |
| muscle of leg | UBERON:0001383 | 96.64 | gold quality |
| muscle organ | UBERON:0001630 | 95.36 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 93.58 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 93.12 | gold quality |
| apex of heart | UBERON:0002098 | 92.76 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 92.60 | gold quality |
| triceps brachii | UBERON:0001509 | 92.28 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 92.12 | gold quality |
| biceps brachii | UBERON:0001507 | 92.11 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.90 | gold quality |
| skin of leg | UBERON:0001511 | 91.79 | gold quality |
| heart left ventricle | UBERON:0002084 | 91.78 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 91.74 | gold quality |
| quadriceps femoris | UBERON:0001377 | 91.62 | gold quality |
| vastus lateralis | UBERON:0001379 | 91.62 | gold quality |
| cardiac ventricle | UBERON:0002082 | 91.47 | gold quality |
| monocyte | CL:0000576 | 91.13 | gold quality |
| right atrium auricular region | UBERON:0006631 | 91.06 | gold quality |
| omental fat pad | UBERON:0010414 | 90.91 | gold quality |
| peritoneum | UBERON:0002358 | 90.88 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 90.88 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 90.82 | gold quality |
| mononuclear cell | CL:0000842 | 90.79 | gold quality |
| esophagus mucosa | UBERON:0002469 | 90.71 | gold quality |
| leukocyte | CL:0000738 | 90.70 | gold quality |
| zone of skin | UBERON:0000014 | 90.41 | gold quality |
| transverse colon | UBERON:0001157 | 90.34 | gold quality |
| esophagus | UBERON:0001043 | 90.14 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.30 |
| E-MTAB-7303 | no | 232.49 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ZBTB17
miRNA regulators (miRDB)
28 targeting TMEM11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-5571-5P | 99.49 | 66.99 | 1764 |
| HSA-MIR-122B-5P | 99.46 | 70.81 | 1457 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-324-3P | 99.26 | 66.31 | 1034 |
| HSA-MIR-548AS-3P | 99.12 | 69.12 | 2294 |
| HSA-MIR-3160-3P | 99.07 | 64.78 | 955 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-760 | 98.81 | 66.65 | 1392 |
| HSA-MIR-6769B-5P | 98.73 | 64.91 | 1092 |
| HSA-MIR-4680-3P | 98.64 | 68.60 | 2093 |
| HSA-MIR-6818-3P | 98.56 | 68.23 | 1307 |
| HSA-MIR-6769A-5P | 97.99 | 64.16 | 851 |
| HSA-MIR-558 | 97.50 | 67.16 | 977 |
| HSA-MIR-5187-3P | 97.28 | 67.10 | 1037 |
| HSA-MIR-5579-5P | 96.32 | 68.54 | 730 |
| HSA-MIR-541-3P | 96.07 | 66.11 | 1271 |
| HSA-MIR-654-5P | 96.07 | 66.18 | 1280 |
| HSA-MIR-6781-5P | 94.61 | 59.49 | 155 |
| HSA-MIR-6826-5P | 93.80 | 67.42 | 514 |
Literature-anchored findings (GeneRIF, showing 2)
- study demonstrates that the Drosophila PMI gene and its human orthologue TMEM11 encode mitochondrial inner-membrane proteins that regulate mitochondrial morphogenesis (PMID:21274005)
- The outer mitochondrial membrane protein TMEM11 demarcates spatially restricted BNIP3/BNIP3L-mediated mitophagy. (PMID:36795401)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem11 | ENSDARG00000070866 |
| mus_musculus | Tmem11 | ENSMUSG00000043284 |
| rattus_norvegicus | Tmem11 | ENSRNOG00000005377 |
| drosophila_melanogaster | Pmi | FBGN0044419 |
Protein
Protein identifiers
Transmembrane protein 11, mitochondrial — P17152 (reviewed: P17152)
Alternative names: Protein PM1, Protein PMI
All UniProt accessions (1): P17152
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in mitochondrial morphogenesis.
Subunit / interactions. Associates with the mitochondrial contact site and cristae organizing system (MICOS) complex, composed of at least MICOS10/MIC10, CHCHD3/MIC19, CHCHD6/MIC25, APOOL/MIC27, IMMT/MIC60, APOO/MIC23/MIC26 and QIL1/MIC13. This complex was also known under the names MINOS or MitOS complex. The MICOS complex associates with mitochondrial outer membrane proteins SAMM50, MTX1, MTX2 and DNAJC11, mitochondrial inner membrane protein TMEM11 and with HSPA9. Interacts with IMMT/MIC60.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the TMEM11 family.
RefSeq proteins (1): NP_003867* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026120 | TMEM11 | Family |
Pfam: PF14972
UniProt features (4 total): transmembrane region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17152-F1 | 79.14 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8949613 | Cristae formation |
MSigDB gene sets: 146 (showing top):
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10, MORF_MSH3, MORF_BRCA1, MORF_ATRX, MORF_ESR1, MORF_PPP5C, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, MORF_FANCG, GOCC_MITOCHONDRIAL_ENVELOPE, HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN, MORF_RAP1A, GOBP_MEMBRANE_ORGANIZATION, FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN, MORF_MT4, MORF_PPP2R5B
GO Biological Process (2): mitochondrion organization (GO:0007005), inner mitochondrial membrane organization (GO:0007007)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial biogenesis | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle organization | 1 |
| mitochondrial membrane organization | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1202 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM11 | RRAGA | Q7L523 | 764 |
| TMEM11 | RRAGB | Q5VZM2 | 706 |
| TMEM11 | HRAS | P01112 | 544 |
| TMEM11 | RRAGC | Q9HB90 | 497 |
| TMEM11 | RRAGD | Q9NQL2 | 497 |
| TMEM11 | APOOL | Q6UXV4 | 486 |
| TMEM11 | CCR5 | P51681 | 479 |
| TMEM11 | SMIM20 | Q8N5G0 | 479 |
| TMEM11 | IMMT | Q16891 | 475 |
| TMEM11 | ARL6IP4 | Q66PJ3 | 474 |
| TMEM11 | DNAJC11 | Q9NVH1 | 468 |
| TMEM11 | MTX2 | O75431 | 454 |
| TMEM11 | NUB1 | Q9Y5A7 | 447 |
| TMEM11 | TMEM117 | Q9H0C3 | 436 |
| TMEM11 | KDELR1 | P24390 | 431 |
IntAct
238 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BNIP3 | BNIP3L | psi-mi:“MI:0914”(association) | 0.970 |
| BNIP3 | TMEM11 | psi-mi:“MI:0915”(physical association) | 0.920 |
| TMEM11 | BNIP3 | psi-mi:“MI:0915”(physical association) | 0.920 |
| BNIP3L | TMEM11 | psi-mi:“MI:0915”(physical association) | 0.840 |
| TMEM11 | BNIP3L | psi-mi:“MI:0915”(physical association) | 0.840 |
| TMEM11 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.700 |
| KASH5 | TMEM11 | psi-mi:“MI:0915”(physical association) | 0.700 |
| TMEM11 | FATE1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TMEM11 | CREB3L1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TNFSF14 | TMEM11 | psi-mi:“MI:0915”(physical association) | 0.670 |
| BCAM | LAMA5 | psi-mi:“MI:0914”(association) | 0.640 |
| LRRC32 | SMPD2 | psi-mi:“MI:0914”(association) | 0.640 |
| TMEM11 | MRM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM11 | GJB4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM11 | RNASEH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM11 | MUC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM11 | YIPF6 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (136): TMEM11 (Two-hybrid), TMEM11 (Two-hybrid), TMEM11 (Affinity Capture-RNA), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Two-hybrid), TMEM11 (Two-hybrid), TMEM11 (Affinity Capture-Western), FATE1 (Two-hybrid), CREB3L1 (Two-hybrid), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS)
ESM2 similar proteins: A2BD92, A4FV45, A5D7N3, A7S641, B0BN86, D3Z2R5, F1Q930, O76024, O95870, P17152, P97587, Q0IJ20, Q17QW2, Q1JPD2, Q1JPG0, Q2HJ63, Q3B8H3, Q4QQM5, Q5BK13, Q5BLE2, Q5RAS8, Q5RJQ8, Q5SWK7, Q5SYH2, Q5ZLD4, Q66H44, Q6DC66, Q6DF19, Q6GR21, Q6MG55, Q6NRI4, Q6NUQ4, Q6NWH5, Q6ZQE4, Q7L4E1, Q7SZC5, Q7ZW11, Q7ZWF4, Q7ZYA0, Q810L4
Diamond homologs: A2BD92, A5D7N3, B0BN86, P17152, Q3B8H3, Q5ZLD4, Q6NWH5, Q8BK08, Q8IQ56
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
20 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
607 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:21198844:T:C | acceptor_gain | 1.0000 |
| 17:21198857:C:CT | acceptor_gain | 1.0000 |
| 17:21198858:A:T | acceptor_gain | 1.0000 |
| 17:21198840:CCTTT:C | acceptor_gain | 0.9900 |
| 17:21198844:T:TC | acceptor_gain | 0.9900 |
| 17:21198847:A:AC | acceptor_gain | 0.9900 |
| 17:21214085:TCTCA:T | donor_loss | 0.9900 |
| 17:21214086:CTCA:C | donor_loss | 0.9900 |
| 17:21214087:TCA:T | donor_loss | 0.9900 |
| 17:21214088:CA:C | donor_loss | 0.9900 |
| 17:21214089:A:AT | donor_loss | 0.9900 |
| 17:21214090:CCTC:C | donor_loss | 0.9900 |
| 17:21198836:TCACC:T | acceptor_gain | 0.9800 |
| 17:21198837:CACC:C | acceptor_gain | 0.9800 |
| 17:21198837:CACCC:C | acceptor_gain | 0.9800 |
| 17:21198839:CC:C | acceptor_gain | 0.9800 |
| 17:21198841:C:CC | acceptor_gain | 0.9800 |
| 17:21198847:A:C | acceptor_gain | 0.9800 |
| 17:21208442:T:TA | donor_gain | 0.9800 |
| 17:21214090:CCT:C | donor_gain | 0.9800 |
| 17:21214090:CCTCT:C | donor_gain | 0.9800 |
| 17:21214089:A:AC | donor_gain | 0.9700 |
| 17:21214090:C:CC | donor_gain | 0.9700 |
| 17:21198843:T:TC | acceptor_gain | 0.9600 |
| 17:21203736:C:CA | donor_gain | 0.9600 |
| 17:21198842:T:C | acceptor_gain | 0.9500 |
| 17:21208405:T:TA | donor_gain | 0.9500 |
| 17:21214134:T:TA | donor_gain | 0.9500 |
| 17:21214340:AGT:A | donor_gain | 0.9500 |
| 17:21198842:T:TC | acceptor_gain | 0.9400 |
AlphaMissense
1224 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:21198427:A:G | L159P | 1.000 |
| 17:21198427:A:T | L159Q | 1.000 |
| 17:21198502:T:C | Y134C | 1.000 |
| 17:21198503:A:G | Y134H | 1.000 |
| 17:21198517:T:A | D129V | 1.000 |
| 17:21198525:C:A | W126C | 1.000 |
| 17:21198525:C:G | W126C | 1.000 |
| 17:21198527:A:G | W126R | 1.000 |
| 17:21198527:A:T | W126R | 1.000 |
| 17:21198670:C:A | G78V | 1.000 |
| 17:21198670:C:T | G78D | 1.000 |
| 17:21198671:C:A | G78C | 1.000 |
| 17:21198671:C:G | G78R | 1.000 |
| 17:21198683:A:G | W74R | 1.000 |
| 17:21198683:A:T | W74R | 1.000 |
| 17:21198700:C:T | G68D | 1.000 |
| 17:21198718:A:T | I62N | 1.000 |
| 17:21198724:A:T | I60N | 1.000 |
| 17:21198745:A:G | L53P | 1.000 |
| 17:21198757:A:G | L49P | 1.000 |
| 17:21198427:A:C | L159R | 0.999 |
| 17:21198430:A:T | V158E | 0.999 |
| 17:21198499:T:G | Q135P | 0.999 |
| 17:21198502:T:G | Y134S | 0.999 |
| 17:21198503:A:C | Y134D | 0.999 |
| 17:21198510:G:C | C131W | 0.999 |
| 17:21198511:C:T | C131Y | 0.999 |
| 17:21198512:A:G | C131R | 0.999 |
| 17:21198517:T:C | D129G | 0.999 |
| 17:21198517:T:G | D129A | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000091112 (17:21208912 G>A), RS1000155343 (17:21207658 C>A,G,T), RS1000229106 (17:21202992 G>A), RS1000239197 (17:21203226 A>T), RS1000351856 (17:21210927 T>A), RS1000588714 (17:21209247 G>A), RS1000594335 (17:21204704 T>C), RS1000863410 (17:21200631 C>G,T), RS1001148476 (17:21199259 G>A), RS1001172428 (17:21214948 C>A,T), RS1001581934 (17:21211326 C>T), RS1001638608 (17:21199076 C>A), RS1001701636 (17:21205968 G>A,C), RS1001862959 (17:21205422 G>C), RS1001929448 (17:21203704 A>G)
Disease associations
OMIM: gene MIM:618817 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_14 | Body mass index | 5.000000e-10 |
| GCST009391_1409 | Metabolite levels | 7.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0005132 | 5-HIAA measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, affects cotreatment, increases methylation | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| FR900359 | increases phosphorylation | 1 |
| testosterone enanthate | affects expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| sodium arsenite | affects binding, increases reaction | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| corosolic acid | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Decitabine | affects methylation | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Atrazine | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Vitamin E | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.